MGLAX | MGLCX | MGLAX / MGLCX | |
Total Expense Ratio | 1.19 | 1.94 | 61% |
Annual Report Gross Expense Ratio | 1.20 | 1.95 | 62% |
Fund Existence | 16 years | 11 years | - |
Gain YTD | 3.500 | 3.043 | 115% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.22B | 2.22B | 100% |
Annual Yield % from dividends | 2.25 | 1.29 | 174% |
Returns for 1 year | 2.15 | 1.39 | 155% |
Returns for 3 years | -4.47 | -6.36 | 70% |
Returns for 5 years | 13.27 | 9.38 | 142% |
Returns for 10 years | 28.83 | 9.12 | 316% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HAGCX | 54.35 | 0.49 | +0.91% |
Carillon Eagle Mid Cap Growth C | |||
VYMQX | 19.00 | 0.15 | +0.80% |
Voya Mid Cap Research Enhanced Index A | |||
GLCCX | 21.93 | 0.13 | +0.60% |
Goldman Sachs Large Cap Gr Insghts C | |||
GMXPX | 24.48 | 0.07 | +0.29% |
Goldman Sachs Large Cp Val Insghts P | |||
LHCIX | 18.56 | 0.05 | +0.27% |
Lord Abbett Health Care I |